Clin Mol Hepatol.
2024 Apr;30(2):154-156. 10.3350/cmh.2024.0120.
Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen
- Affiliations
-
- 1Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
- 2Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan
- 3Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan
- KMID: 2554417
- DOI: http://doi.org/10.3350/cmh.2024.0120
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?
- Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
- The mechanism and treatment of anti-viral resistant hepatitis B virus
- Prophylactic Antiviral Treatment in Immunosuppressed Chronic Hepatitis B Patients
- Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
